Gum disease and hepatitis: a hidden connection revealed?
NCT ID NCT07491848
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the link between gum (periodontal) disease and hepatitis B+D infection, and whether the drug bulevirtide changes that relationship. Researchers will measure inflammation markers in saliva and gum fluid from 25 adults: those with hepatitis B+D on bulevirtide, those not on the drug, and healthy volunteers. The goal is to better understand how these conditions interact, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Emergency County Hospital Craiova
RECRUITINGCraiova, Romania
-
University of Medicine and Pharmacy of Craiova
RECRUITINGCraiova, Romania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Blood-Derived clot may regrow bone in gum disease
- Can gum disease be stopped by targeting these genes?
- Could saliva hold the key to understanding gum disease?
- Can a gentler Deep-Clean beat standard gum therapy?
- Could a toothpaste ingredient reshape the microbes behind gum disease?